- Home
- AFYA
AFYA
Afya Limited
as of 12-11-2025 11:12am EST
Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.
| Founded: | 1999 | Country: | Brazil |
| Employees: | N/A | City: | N/A |
| Market Cap: | 1.4B | IPO Year: | 2019 |
| Target Price: | $18.10 | AVG Volume (30 days): | 79.8K |
| Analyst Decision: | Hold | Number of Analysts: | 5 |
| Dividend Yield: | Dividend Payout Frequency: | N/A | |
| EPS: | 1.50 | EPS Growth: | 25.39 |
| 52 Week Low/High: | $13.47 - $19.90 | Next Earning Date: | 11-12-2025 |
| Revenue: | $681,742,784 | Revenue Growth: | 14.07% |
| Revenue Growth (this year): | 14.61% | Revenue Growth (next year): | 8.34% |
AI-Powered AFYA Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Compare AFYA vs Leading Stocks
See how AFYA stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "AFYA Afya Limited - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.